9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Although Africa is a region of hyper endemicity to viral hepatitis B (HBV) and C (HCV) infections, there is limited data on their related burden among pregnant women. The present systematic review and meta-analysis aimed to determine the magnitude of these infections among pregnant women living in Africa and investigate its association with gender-related human development indicators.

          Main text

          We searched PubMed, Embase, Web of Science, Africa Journal Online, and Global Index Medicus, with no language restriction, to identify observational studies on HBV and HCV infections in pregnant women residing in Africa published from January 1, 2000 until December 31, 2017. Eligible studies reported the prevalence of HBV and/or HCV infection(s) (HBs antigen and HCV antibodies) and/or infectivity (HBe antigen or detectable HCV viral load). Each study was independently reviewed for methodological quality. We used a random-effects model meta-analysis to pool studies. In total, 145 studies (258 251 participants, 30 countries) were included, of which 120 (82.8%) had a low, 24 (16.5%) a moderate, and one (0.7%) had a high risk of bias. The prevalence of HBV and HCV infections was 6.8% (95% confidence interval [ CI]: 6.1–7.6, 113 studies) and 3.4% (95% CI: 2.6–4.2, 58 studies), respectively. The prevalence of HBe antigen and HCV detectable viral load was 18.9% (95% CI: 14.4–23.9) and 62.3% (95% CI: 51.6–72.5) in HBV positive and HCV positive pregnant women, respectively. The multivariable meta-regression analysis showed that the prevalence of HBV infection increased with decreasing gender development index, males’ level of education and females’ expected years of schooling. Furthermore, this prevalence was higher in rural areas and in western and central Africa. The prevalence of HCV infection increased with decreasing proportion of seats held by women in parliament.

          Conclusions

          To address the burden of HBV and HCV infections, beyond well-known risk factors at the individual-level, macro-level factors including gender-related human development indicators and dwelling in rural areas should be considered. In Africa, HBV or HCV infected mothers seems to have high potential of transmission to their children.

          Electronic supplementary material

          The online version of this article (10.1186/s40249-019-0526-8) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.

          Hepatitis C virus (HCV) is a major cause of chronic liver disease in the world. The WHO estimates that 3% (170 million) of the world's population are chronically infected with HCV. Sub-Saharan Africa is of great interest because it is reported to have the highest HCV prevalence rate (5.3%), and a concurrent HIV epidemic. In our review of the published literature we found consistent evidence of high HCV prevalence in many countries of Africa. We estimate the overall prevalence of HCV in Sub-Saharan Africa is 3.0%. The central African region has the highest estimated prevalence of 6%, west Africa has an estimated prevalence of 2.4%, and southern and east Africa with the lowest estimated prevalence of 1.6%. Given low sexual transmission of HCV and infrequency of intravenous drug use in Sub-Saharan Africa, iatrogenic causes of HCV transmission need to be further evaluated.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Gender roles and traits in stress and health

            Eric Mayor (2015)
            Women have a life-expectancy advantage over men, but a marked disadvantage with regards to morbidity. This is known as the female–male health-survival paradox in disciplines such as medicine, medical sociology, and epidemiology. Individual differences in physical and mental health are further notably explained by the degree of stress individuals endure, with women being more affected by stressors than men. Here, we briefly examine the literature on women’s disadvantage in health and stress. Beyond biological considerations, we follow with socio-cognitive explanations of gender differences in health and stress. We show that gender roles and traits (masculinity in particular) explain part of the gender differences in stress, notably cognitive appraisal and coping. Stress in turn degrades health. Implications are discussed. In conclusion, traditional socialization is advantageous for men in terms of health.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Pregnancy outcomes associated with viral hepatitis.

              The aim of this study was to examine the contribution of hepatitis B virus (HBV) and hepatitis C virus (HCV) to pregnancy-related complications including gestational diabetes mellitus (GDM), preterm birth (PTB), intrauterine growth restriction (IUGR), pre-eclampsia, antepartum haemorrhage and cholestasis. The Nationwide Inpatient Sample was queried for all pregnancy-related discharges, pregnancy complications and viral hepatitis from 1995 to 2005. Logistic regression was used to examine the association between HBV, HCV, HBV + HCV and pregnancy-related complications including GDM, PTB, IUGR, pre-eclampsia, antepartum haemorrhage, cholestasis and caesarean delivery. Model covariates included maternal age, race, insurance status, substance use and medical complications including liver complication, hypertension, HIV, anaemia, thrombocytopenia and sexually transmitted infections. Of 297 664 pregnant women data available for analysis, 1446 had a coded diagnosis of HBV, HCV or both. High-risk behaviours, such as smoking, alcohol and substance use were higher in women with either HBV or HCV. Women with HBV had an increased risk for PTB (aOR 1.65, CI [1.3, 2.0]) but a decreased risk for caesarean delivery (aOR 0.686, CI [0.53, 0.88]). Individuals with HCV had an increased risk for GDM (aOR 1.6, CI [1.0, 2.6]). Individuals with both HBV and HCV co-infection had an increased risk for antepartum haemorrhage (aOR 2.82, CI [1.1, 7.2]). There was no association of viral hepatitis with IUGR or pre-eclampsia. Women with hepatitis have an increased risk for complications during pregnancy. Research to determine the efficacy and cost-effectiveness of counselling patients about potential risks for adverse outcomes is warranted. © 2011 Blackwell Publishing Ltd.
                Bookmark

                Author and article information

                Contributors
                bignarimjj@yahoo.fr
                angels.kens@yahoo.fr
                aghiles.hamroun@gmail.com
                ndangangmarie@live.fr
                joycefoka@yahoo.fr
                ntounouga@gmail.com
                remi.lenain@orange.fr
                marieamougou164@yahoo.com
                jobertrichie_nansseu@yahoo.fr
                Journal
                Infect Dis Poverty
                Infect Dis Poverty
                Infectious Diseases of Poverty
                BioMed Central (London )
                2095-5162
                2049-9957
                4 March 2019
                4 March 2019
                2019
                : 8
                : 16
                Affiliations
                [1 ]Department of Epidemiology and Public Health, Centre Pasteur of Cameroon, P.O. Box 1274, Yaoundé, Cameroon
                [2 ]ISNI 0000 0001 2171 2558, GRID grid.5842.b, Faculty of Medicine, , University of Paris Sud, ; Le Kremlin-Bicetre, France
                [3 ]ISNI 0000 0004 0471 8845, GRID grid.410463.4, Department of Nephrology, , Huriez Hospital, Lille University Hospital, ; Lille, France
                [4 ]GRID grid.41724.34, Department of Medical Information and Informatics, , Rouen University Hospital, ; Rouen, France
                [5 ]ISNI 0000 0001 2173 8504, GRID grid.412661.6, Faculty of Medicine and Biomedical Sciences, , University of Yaoundé I, ; Yaoundé, Cameroon
                [6 ]GRID grid.4817.a, MethodS in Patient-centered outcomes & HEalth ResEarch (EA 4275 SPHERE), , Nantes University, ; Nantes, France
                [7 ]Department of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon
                [8 ]ISNI 0000 0001 2173 8504, GRID grid.412661.6, Faculty of Sciences, , University of Yaoundé I, ; Yaoundé, Cameroon
                [9 ]ISNI 0000 0001 0668 6654, GRID grid.415857.a, Department for the Control of Disease, Epidemics and Pandemics, Ministry of Public Health, ; Yaoundé, Cameroon
                [10 ]ISNI 0000 0001 2173 8504, GRID grid.412661.6, Department of Public Health, Faculty of Medicine and Biomedical Sciences, , University of Yaoundé I, ; Yaoundé, Cameroon
                Author information
                http://orcid.org/0000-0001-8018-6279
                Article
                526
                10.1186/s40249-019-0526-8
                6398223
                30827278
                92e755f8-c11a-4f5a-a97a-6c05c3188fcc
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 15 November 2018
                : 11 February 2019
                Categories
                Scoping Review
                Custom metadata
                © The Author(s) 2019

                hepatitis b,hepatitis c,development,africa,gender,pregnant,women health

                Comments

                Comment on this article